Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN for Secondary progressive multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where RIZATRIPTAN was used for Secondary progressive multiple sclerosis.

Most Reported Side Effects for RIZATRIPTAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,041 36.0% 2 88
Off label use 522 18.0% 0 27
Nausea 447 15.4% 1 26
Product use in unapproved indication 423 14.6% 0 20
Headache 335 11.6% 2 61
Hyperhidrosis 333 11.5% 0 19
Migraine 329 11.4% 0 79
Sedation 320 11.1% 1 1
Nightmare 314 10.8% 0 0
Drug intolerance 240 8.3% 0 41
Nephrolithiasis 240 8.3% 0 3
Drug ineffective for unapproved indication 228 7.9% 1 16
Hypersensitivity 216 7.5% 2 37
Swelling face 174 6.0% 2 11
Dysphonia 172 5.9% 0 14

Other Indications for RIZATRIPTAN

Migraine (1,365) Product used for unknown indication (762) Headache (129) Migraine with aura (26) Attention deficit hyperactivity disorder (21) Migraine without aura (18) Migraine prophylaxis (15) Hypoaesthesia (10) Suicidal ideation (9) Depression (8)

Other Drugs Used for Secondary progressive multiple sclerosis

SIPONIMOD (2,265) OCRELIZUMAB (1,273) OFATUMUMAB (1,099) FINGOLIMOD (351) INTERFERON BETA-1B (146) RITUXIMAB (131) NATALIZUMAB (115) DIMETHYL (96) INTERFERON BETA-1A (89) RABEPRAZOLE (86)

Related Pages

RIZATRIPTAN Full Profile All Secondary progressive multiple sclerosis Drugs RIZATRIPTAN Demographics RIZATRIPTAN Timeline